EmbectavsUnitedHealth

EMBC and UNH stock compared: price, dividend, valuation and results, from SEC filings.

EMBC

Embecta Corp.

$6.02

Value $352M

-2.75%
EMBC's page

UNH

UnitedHealth Group Incorporated

$339.85

Value $308B

+2.84%
UNH's page

Embecta (EMBC) has a market value of $352M and UnitedHealth (UNH) $308B. Over the last year, with dividends, EMBC moved -56.0% and UNH +12.9%. The P/E is 4.0 for EMBC and 19.4 for UNH. Dividend yield: EMBC 5.32%, UNH 2.67%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    EMBC$352M

    UNH$308B

    UNH is 876 times EMBC

  • Revenue, 12 months

    EMBC$1.0B

    UNH$450B

    UNH is 441 times EMBC

  • Net income, 12 months

    EMBC$88M

    UNH$15.9B

    UNH is 182 times EMBC

  • Operating margin

    EMBC21.9%

    UNH5.3%

    16.6 points apart

  • ROIC

    EMBC20.4%

    UNH11.3%

    9.1 points apart

  • P/E

    EMBC4.0

    UNH19.4

    UNH is 4.8 times EMBC

  • Dividend yield

    EMBC5.3%

    UNH2.7%

    2.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

EMBC-58.6%

UNH-32.4%

50100202420252026
Returns by period
PeriodEMBCWith dividendsUNHWith dividends
1 year since November 19, 2025-56.0%Price -57.4%+12.9%Price +10.0%
3 years since November 20, 2023-58.6%-25.5% a yearPrice -63.1%-32.4%-12.2% a yearPrice -36.5%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

EMBCEmbectaUNHUnitedHealth

Valuation

EMBCUNH
Valuation
Price$6.02$339.85
Market value$352M$308B
Enterprise value (EV)$1.6B$354B
P/E4.019.4
P/E, 5-year median9.625.0
P/B–3.0
EV/EBIT7.314.8
Free cash flow yield46.7%7.4%

Results and growth

EMBCUNH
Results and growth
Revenue, 12 months$1.0B$450B
Net income, 12 months$88M$15.9B
Free cash flow, 12 months$165M$22.8B
Earnings per share, 12 months$1.47$17.52
Revenue growth, year on year-3.8%11.8%
Revenue growth a year, past-0.1%over 5 years+11.7%over 5 years
EPS growth a year, past-26.4%over 5 years-3.8%over 5 years

Margins and returns on capital

EMBCUNH
Margins and returns on capital
Gross margin59.0%88.3%
Operating margin21.9%5.3%
Net margin8.6%3.5%
ROIC20.4%11.3%
ROE–15.5%

Balance sheet

EMBCUNH
Balance sheet
Cash$215M$28.5B
Total debt$1.5B$74.3B
Net debt / EBITDA4.81.6
Interest cover–6.2×

Dividends and buybacks

EMBCUNH
Dividends and buybacks
Dividend yield5.3%2.7%
Dividend per share, 12 months$0.32$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield–1.8%
Shareholder yield5.3%4.5%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: EMBC or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Embecta or UnitedHealth?

By market value, UnitedHealth ($308B) is about 875.7 times Embecta ($352M), at today's prices.

How did EMBC and UNH stock do over the last 3 years?

Since November 20, 2023, EMBC's price moved -63.1% and UNH's -36.5%. With dividends: EMBC -58.6% (-25.5% a year), UNH -32.4% (-12.2% a year). Past returns do not predict future ones.

Which pays the higher dividend, EMBC or UNH?

The dividend yield at today's price is 5.32% for Embecta and 2.67% for UnitedHealth. Over the last twelve months they paid $0.32 and $9.06 per share.

What is the P/E of EMBC and UNH?

At today's price, the P/E is 4.0 for EMBC and 19.4 for UNH. The median of the last five years was 9.6 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, Embecta or UnitedHealth?

Over the last twelve months, the net margin was 8.6% for Embecta and 3.5% for UnitedHealth, and the operating margin 21.9% and 5.3%. Revenue was $1.0B and $450B.

Which is the better investment, Embecta or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.